Meta‑analysis Finds 9% of Teens Tried Weight‑loss Supplements, Half Use Protein Products

Why It Matters

The surge in teen supplement use intersects with rising rates of body‑image disorders, putting a vulnerable population at risk for adverse health outcomes such as hormonal imbalance, kidney strain, and nutrient deficiencies. By quantifying the prevalence of weight‑loss and performance‑enhancing products, the study provides a data‑driven foundation for policymakers to justify stricter oversight and for health professionals to develop targeted screening tools. Beyond individual health, the trend signals a broader shift in how young people obtain nutrition advice—moving from clinicians to influencers and e‑commerce platforms. Addressing this shift will require coordinated action across regulatory agencies, schools, and the tech industry to ensure that accurate, safe information outweighs marketing hype.

Key Takeaways

• 9% of adolescents have tried nonprescription weight‑loss products; 6% did so in the past year.
• More than 50% of teen boys report using protein powders or shakes; 33% of girls and 55% of boys reported protein use in 2022.
• 25.7% of adolescent boys have used creatine, according to a 2024 review.
• Over 30% of U.S. children use dietary supplements regularly, per a global narrative review.
• Researchers from Harvard, Deakin and Monash analyzed 90 studies covering 604,000 participants under 18.

Pulse Analysis

The meta‑analysis shines a light on a market that has grown faster than the regulatory framework designed to protect consumers. Historically, the supplement industry has operated under the Dietary Supplement Health and Education Act of 1994, which treats products more like foods than drugs, allowing manufacturers to market without pre‑approval. The current data suggest that this loophole is now exposing teenagers to products that can have pharmacologic effects, especially when combined with high‑intensity sports or dieting.

From a market perspective, the $140 billion global supplement industry is likely to see a recalibration of its growth strategy. Brands that have relied on influencer partnerships may need to pivot toward transparent ingredient sourcing and clinical validation to retain credibility. Simultaneously, insurers and pediatric practices could see an uptick in consultations related to supplement‑induced complications, prompting a potential rise in preventive screening costs.

Looking ahead, the convergence of social‑media algorithms, direct‑to‑consumer sales, and lax oversight creates a perfect storm for adolescent exposure. Effective mitigation will require not only tighter FDA enforcement but also digital‑platform policies that limit targeted advertising of weight‑loss and performance‑enhancing products to minors. If policymakers act decisively, the next wave of regulation could set a precedent for how emerging nutrition trends are governed in the digital age.